News from Tuesday, May 20, 2025
Articles
Real-World Evidence in CNS Research: Past, Present, Future
(5/20, Bruce Hellman, PharmaPhorum) reports “...Over the next 18 months to two years, we are very likely to see continued growth in the use of RWE in CNS studies. More sponsors are paying attention to RWE, and the industry is collecting data sets of increasing size and quality...The focus must be on ensuring that the study is designed collaboratively with patients and on delivering a patient-centric experience that helps to maintain engagement, promote retention, and support high data capture compliance.” Full
Podcast: Over The Counter: Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer
(5/20, David Ridley, HBW Insight) comments “In part 2 of HBW Insight's interview, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, explains how to approach real world evidence so that regulators recognize its validity, in supporting Rx-to-OTC switch applications, for example.” Subscription Required
Value-Based Care Revenue Expected to Increase in 2025, Survey Respondents Agree
(5/16, Noah Tong, Fierce Healthcare) reports “...The findings indicate a growing reliance on VBC programs for some organizations. A significant segment, 30%, of organizations said a quarter of their revenue is tied to VBC contracts. More than 20% indicated at least half of their revenue is derived from fully capitated or downside risk contracts.” Full
It’s Time to Bring Value-Based Care Principles to Hospice
(5/20, Asher Perzigian, Medical Economics) reports “...As our population ages and the demand for hospice care grows, we need to ensure that this vital service meets the highest standards. Applying VBC principles can help. By integrating hospice into the full continuum of care and investing in innovative tools, we can address workforce shortages, improve care quality and access, and set the stage for a more compassionate and effective health care system.” Full
Press Releases
Evidence Assessments, Key to Separating Fact From Fiction in Healthcare, Get a Revamp From ECRI
(5/20, ECRI) “...ECRI CEA reports outline the potential impact of the intervention on the health system in terms of cost, infrastructure, and care. They also transparently appraise each study and calculate the risk of bias, a critical component for clinicians and payors who seek to understand if the results of a controlled trial can be replicated in a real-world treatment environment. In addition, a new section on equity considerations describes the extent to which the technology or intervention may exacerbate, mitigate, or have no effect on health disparities in terms of patient representation in clinical trials, burden of care, patient-level barriers, and implementation barriers.” Full
Events
Roundtable: Navigating the JCA: Real-World Evidence and the Future of HTA
June 24, 2025
17:00-21:00 BST
Russell Square, London